Unilateral Meniere Disease: Can Double Dose Gadolinium and Delayed Imaging Make the Diagnosis?

Withdrawn before enrolling · Not applicable

Conditions studied: Meniere Disease

In brief

The purpose of this research study is to see if magnetic resonance imaging (MRI) with a double dose of contrast, or dye, and delayed imaging with MRI can help to diagnose Meniere Disease.

Key facts

Study ID

NCT02371798

Run by

Emory University

People needed

0

Starts

2015-02-01

Expected to finish

2016-11-01

Last updated by the study team

2016-12-01

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of unilateral Meniere Disease (MD) per the Committee on Hearing and Equilibrium of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS)
• Glomerular filtration rate (GFR) > 90 mls/min/1.73 m2
• Creatinine (Cr) level serum < 1.6 mg/dl

You may not qualify if…

• Age < 18 years
• Diagnosis of bilateral MD
• History of prior temporal bone surgery
• History of cochlear implant placement
• Pacemaker, cardiac implantable electronic device, shrapnel, aneurysm clips or other metal objects that are prohibited in the MR suite
• GFR < 90 mls/min/1.73m2
• Cr level > 1.6 mg/d
• Lack of IV access
• Contrast allergy to gadolinium agent
• Pregnancy
• Claustrophobia necessitating parenteral anxiolytics
• Patients who are unable to provide informed consent for themselves

Where it is running

• Emory University Department of Otolaryngology Clinic — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.